Advancing Cervical Cancer Prevention Initiatives in
Resource-Constrained Settings: Insights from the Cervical Cancer Prevention
Program in Zambia
article has not abstract
Vyšlo v časopise:
Advancing Cervical Cancer Prevention Initiatives in
Resource-Constrained Settings: Insights from the Cervical Cancer Prevention
Program in Zambia. PLoS Med 8(5): e32767. doi:10.1371/journal.pmed.1001032
Kategorie:
Health in Action
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1001032
Souhrn
article has not abstract
Zdroje
1. FerlayJShinHRBrayFFormanDMathersC
2010
Estimates of worldwide burden of cancer in 2008: GLOBOCAN
2008.
Int J Cancer
127
2893
2917
2. SankaranarayananREsmyPORajkumarRMuwongeRSwaminathanR
2007
Effect of visual screening on cervical cancer incidence and
mortality in Tamil Nadu, India: a cluster-randomised trial.
Lancet
370
398
406
3. BlumenthalPDGaffikinLDeganusSLewisREmersonM
2007
Cervical cancer prevention: safety, acceptability, and
feasibility of a single-visit approach in Accra, Ghana.
Am J Obstet Gynecol
196
407
e401–408; discussion 407 e408–409
4. GaffikinLBlumenthalPDEmersonMLimpaphayomK
2003
Safety, acceptability, and feasibility of a single-visit approach
to cervical-cancer prevention in rural Thailand: a demonstration
project.
Lancet
361
814
820
5. SankaranarayananRBoffettaP
2010
Research on cancer prevention, detection and management in low-
and medium-income countries.
Ann Oncol
21
1935
1943
6. GakidouENordhagenSObermeyerZ
2008
Coverage of cervical cancer screening in 57 countries: low
average levels and large inequalities.
PLoS Med
5
e132
doi:10.1371/journal.pmed.0050132
7. MwanahamuntuMHSahasrabuddheVVPfaendlerKSMudendaVHicksML
2009
Implementation of ‘see-and-treat’ cervical cancer
prevention services linked to HIV care in Zambia.
AIDS
23
N1
N5
8. ParhamGPMwanahamuntuMHPfaendlerKSSahasrabuddheVVMyungD
2010
eC3–a modern telecommunications matrix for cervical cancer
prevention in Zambia.
J Low Genit Tract Dis
14
167
173
9. ParhamGPSahasrabuddheVVMwanahamuntuMHShepherdBEHicksML
2006
Prevalence and predictors of squamous intraepithelial lesions of
the cervix in HIV-infected women in Lusaka, Zambia.
Gynecol Oncol
103
1017
1022
10. SahasrabuddheVVMwanahamuntuMHVermundSHHuhWKLyonMD
2007
Prevalence and distribution of HPV genotypes among HIV-infected
women in Zambia.
Br J Cancer
96
1480
1483
11. ParhamGPMwanahamuntuMHSahasrabuddheVVWestfallAOKingKE
2010
Implementation of cervical cancer prevention services for
HIV-infected women in Zambia: measuring program
effectiveness.
HIV Therapy
4
713
722
12. PfaendlerKSMwanahamuntuMHSahasrabuddheVVMudendaVStringerJS
2008
Management of cryotherapy-ineligible women in a
“screen-and-treat” cervical cancer prevention program targeting
HIV-infected women in Zambia: lessons from the field.
Gynecol Oncol
110
402
407
13. ChirwaSMwanahamuntuMKapambweSMkumbaGStringerJ
2010
Myths and misconceptions about cervical cancer among Zambian
women: rapid assessment by peer educators.
Glob Health Promot
17
47
50
14. FarmerPFrenkJKnaulFMShulmanLNAlleyneG
2010
Expansion of cancer care and control in countries of low and
middle income: a call to action.
Lancet
376
1186
1193
15. StringerJSZuluILevyJStringerEMMwangoA
2006
Rapid scale-up of antiretroviral therapy at primary care sites in
Zambia: feasibility and early outcomes.
JAMA
296
782
793
16. SankaranarayananRNeneBMShastriSSJayantKMuwongeR
2009
HPV screening for cervical cancer in rural India.
N Engl J Med
360
1385
1394
17. DennyLKuhnLHuCCTsaiWYWrightTCJr
2010
Human papillomavirus-based cervical cancer prevention: long-term
results of a randomized screening trial.
J Natl Cancer Inst
102
1557
1567
18. TropeLAChumworathayiBBlumenthalPD
2009
Preventing cervical cancer: stakeholder attitudes toward
CareHPV-focused screening programs in Roi-et Province,
Thailand.
Int J Gynecol Cancer
19
1432
1438
19. DennyCCEmanuelEJ
2008
US health aid beyond PEPFAR: the Mother & Child
Campaign.
JAMA
300
2048
2051
20. QiaoYLSellorsJWEderPSBaoYPLimJM
2008
A new HPV-DNA test for cervical-cancer screening in developing
regions: a cross-sectional study of clinical accuracy in rural
China.
Lancet Oncol
9
929
936
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2011 Číslo 5
- Statinová intolerance
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Co dělat při intoleranci statinů?
- Pleiotropní účinky statinů na kardiovaskulární systém
- DESATORO PRE PRAX: Aktuálne odporúčanie ESPEN pre nutričný manažment u pacientov s COVID-19
Najčítanejšie v tomto čísle
- Low-Dose Adrenaline, Promethazine, and Hydrocortisone in the Prevention of Acute Adverse Reactions to Antivenom following Snakebite: A Randomised, Double-Blind, Placebo-Controlled Trial
- Effectiveness of Early Antiretroviral Therapy Initiation to Improve Survival among HIV-Infected Adults with Tuberculosis: A Retrospective Cohort Study
- Medical Students' Exposure to and Attitudes about the Pharmaceutical Industry: A Systematic Review
- Estimates of Outcomes Up to Ten Years after Stroke: Analysis from the Prospective South London Stroke Register